5:07 PM
 | 
Jul 09, 2010
 |  BC Extra  |  Clinical News

Researchers report semuloparin data

A researcher at McMaster University and colleagues reported a meta-analysis of three Phase III trials comparing a venous thromboembolism (VTE) candidate from sanofi-aventis Group (Euronext:SAN; NYSE:SNY) to the company's marketed Lovenox enoxaparin to...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >